Spinal Cord Stimulation in Treatment of Chronic Benign Pain: Challenges in Treatment Planning and Present Status, a 22-Year Experience

Kumar, Krishna; Hunter, Gary; Demeria, Denny

doi:10.1227/01.neu.0000192162.99567.96

Cited by 429 publications

(435 citation statements)

References 58 publications

Supporting

Mentioning

403

Contrasting

Unclassified

Order By: Relevance

“…The decision tree model was extended by a Markov model used to determine the cost and health outcomes over a 15-year time horizon. This time horizon was taken from the observational study conducted by Kumar et al 113 that presents a Kaplan-Meier survival curve that illustrates subsequent gradual loss of pain control during a 15-year period. Taylor and Taylor first used this model structure to evaluate the cost-effectiveness of SCS compared to CMM.…”

Section: Neuropathic Painmentioning

confidence: 99%

“…According to the 22-year follow-up SCS study conducted by Kumar et al, 113 complications were the result of fractured electrodes, displaced electrodes, hardware malfunctions, biological factors or infections. Taylor et al 49 conducted a systematic review for chronic back and leg pain and FBSS.…”

Section: Long-term Modelmentioning

confidence: 99%

“…In an observational clinical study that assessed clinical predictors of outcomes in 410 SCS patients, Kumar et al 113 reported an annual SCS withdrawal (explantation) rate of 3.24%. This withdrawal rate from SCS was reported to be the result of loss of satisfactory pain relief despite corrective procedures, refusal of the patient to undergo corrective procedures and gradual loss of satisfactory pain relief (with technically functioning electrodes).…”

mentioning

confidence: 99%

“…113 • The model explores the cost and benefits accrued through pain relief over a 15-year period. 113 • In FBSS, the utility for the no pain relief health state was assumed to be equal to the baseline utility across all patients (0.168).…”

mentioning

confidence: 99%

See 3 more Smart Citations

Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation

Simpson

Duenas²,

Holmes³

et al. 2009

Health Technol Assess

190

173

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK.We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) Programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, from the public and consumer groups and from professional bodies such as royal colleges and NHS trusts. These suggestions are carefully prioritised by panels of independent experts (including NHS service users). The HTA Programme then commissions the research by competitive tender. Second, the HTA Programme provides grants for clinical trials for researchers who identify research questions. These are assessed for importance ...

show abstract

Section: Neuropathic Painmentioning

confidence: 99%

Section: Long-term Modelmentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation

Simpson

Duenas²,

Holmes³

et al. 2009

Health Technol Assess

190

173

View full text Add to dashboard Cite

show abstract

“…Kumar et al [11] compared SCS with conventional medical management and found SCS to be statistically superior in achieving more than 50 % pain relief (37 % in the SCS group vs 2 % in the conventional medical management group). Kumar et al [12] also determined in another study that SCS was effective in providing pain relief over both the short term and the long term, with a follow-up period of 97.6 months. In 2011, North et al [13 •• ] published the protocol for the ongoing EVI-DENCE study.…”

Section: Failed Back Surgery Syndromementioning

confidence: 97%

Advances in Spinal Cord Stimulation for Treatment of Chronic Pain

Jung

Ignatius

Schulz

et al. 2013

Curr Phys Med Rehabil Rep

View full text Add to dashboard Cite

Spinal cord stimulation (SCS) continues to gain validation as an effective and safe treatment option for a variety of chronic pain syndromes, including failed back surgery syndrome, complex regional pain syndrome, refractory angina pectoris, and phantom limb pain. Over the past 30 years, SCS has demonstrated successful outcomes in pain reduction, as well as improvement in quality of life and function. Additionally, there are promising developments under way with cervical spine level SCS and non-painrelated indications. Despite the success of SCS thus far, there is still a paucity of randomized control trials, and further clinical research is warranted to better establish SCS's efficacy across its spectrum of applications.

show abstract

Revisiting the WHO Analgesic Ladder for Surgical Management of Pain

McGuire

Slavin

2020

AMA Journal of Ethics

View full text Add to dashboard Cite

The opioid epidemic challenges current attitudes toward pain management and necessitates the reexamination of the World Health Organization (WHO) 3-step analgesic ladder, introduced in 1986 for cancer pain management. Surgical treatment of pain is a logical extension of the original guideline, which is often absent in conversations with patients about treatment options for their pain and consequentially underutilized. However, with concerns growing regarding opioid use, a shift in the stepwise approach of the WHO analgesic ladder in an age of developing technology and surgical offerings could have profound implications for patients and public health. Surgical interventions potentially provide a long-term, cost-effective management strategy to reduce opioid use. This review canvasses surgical options, highlights literature on failed back surgery syndrome and spinal cord stimulation and reconsiders the current ladder approach to pain management. To claim one AMA PRA Category 1 Credit TM for the CME activity associated with this article, you must do the following: (1) read this article in its entirety, (2) answer at least 80 percent of the quiz questions correctly, and (3) complete an evaluation. The quiz, evaluation, and form for claiming AMA PRA Category 1 Credit TM are available through the AMA Ed Hub TM .

show abstract

Spinal Cord Stimulation in Treatment of Chronic Benign Pain: Challenges in Treatment Planning and Present Status, a 22-Year Experience

Abstract: Spinal cord stimulation can provide significant long-term pain relief with improved quality of life and employment. Results of this study will be effective in better defining prognostic factors and reducing complications leading to higher success rates with spinal cord stimulation.

Cited by 429 publications

References 58 publications

Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation

Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation

Advances in Spinal Cord Stimulation for Treatment of Chronic Pain

Revisiting the WHO Analgesic Ladder for Surgical Management of Pain

Contact Info

Product

Resources

About